News & Events - Hillgene Biopharma Co., Ltd.

01 2025.04

''Diving Deeper - A New Track and Platform for Immune Cell Therapy'' IGC Satellite Conference Organized by Hillgene

IGC 2024 (the 8th Immuno-Gene and Cell Therapy Conference) was grandly opened on September 6-7 at the Beijing International Convention Center. During the period from 9:00 a.m. to 12:35 p.m. on Septemb...

04 2025.03

Connecting China and Building Dreams for the Future

December 3rd, 2024 "Building Bridges" conference in the global life sciences sector was held at the J Hotel in Shanghai, organized by the Wallonia Export & Investment Agency Investment a...

13 2025.02

Innovation Source, Health Everlasting | 2024 Biopharmaceutical and Synthetic Biology Expert Exchange Conference

The 2024 Biopharmaceutical and Synthetic Biology Expert Exchange Conference, along with the Annual Meeting of the Gene Technology Engineering Research Center of the Ministry of Education, was held in ...

01 2022.12

NMPA issued the Announcement on “Implementing Electronic Application of Drug Registration”

In order to improve the efficiency of drug review and approval, the National Medical Products Administration has decided to implement electronic submission of drug registration application materials. ...

30 2022.11

MAH issued“Provisions for Supervision and Administration of Drug Quality (Interim)”

On November 29, the State Food and Drug Administration publicly solicited opinions on the "Regulations on the Supervision and Management of Drug Quality by Drug Marketing Authorization Holders&qu...

18 2022.11

Hillgene Was Awarded the Most Promising and Innovative CXO Company of the Top Value Innovative Companies in the Biomedical Science and Technology Industry of China in 2022

On November 10, the 24th Shanghai International Biotechnology and Pharmaceutical Symposium (BIO-FORUM) Series | China Biotechnology and Pharmaceutical Innovation Forum and the 2022 China Biomedical Sc...

03 2022.11

Academician Zhang Dan of Hillgene Was Invited to Attend and Make His Presentation at the 22nd Taihu Economic and Trade Cooperation Meeting of Wuzhong District

On November 1, the 2022 Suzhou Wuzhong (22nd) Taihu Economic and Trade Cooperation Fair was held on the banks of the beautiful Taihu Lake. Academician Zhang Dan, foreign academician of the Russian Aca...

03 2022.11

Congratulations!! Released Globally! ICH Guideline E19, with Academician Zhang Dan as a Working Expert, Was Formally Released and Reached Step 5

According to the ICH official website, ICH Guideline E19 has entered the Step 5 stage of full implementation by ICH members. Academician Zhang Dan, Vice Chairman of Spectrum Biopharma, participated in...

03 2022.11

Big News: Newly released “Good Manufacturing Practice for Cellular Therapy Products (Interim)”!

On October 31, 2022, in order to guide the drug MAH to standardize the production and quality management of cell therapy products, the National Bureau Verification Center issued the "Guidelines f...

03 2022.11

Breaking | Hillgene Was Accepted as a Candidate of the “Unicorn” Enterprises Fostering Program

Science and technology are the primary productive forces. National and regional development cannot be separated from scientific and technological innovation. In order to implement the innovation-drive...

17 2022.10

Big News: FDA issued the finalized version of guidance “Comparability Protocols for Post-approval Changes to the Chemistry, Manufacturing, and Controls Information in an NDA, ANDA, or BLA”

Comparability Protocols for Postapproval Changes to the Chemistry, Manufacturing, and Controls Information in an NDA, ANDA, or BLA (October 2022)On October 13, 2022, the FDA (CDER and CBER) issued the...

13 2022.09

Hillgene Won the BioCon Awards [Annual CDMO Excellence Award]

On September 6, BioCon Expo 2022, the 9th International Biopharmaceutical Conference and Exhibition, was held as scheduled at the Hangzhou International Expo Center. The BioCon Awards Ceremony and the...